Following its near-death experience last year, BNPL provider Zip Co has made a strong comeback. Evans & Partners has initiated coverage
Superloop management has raised FY24 earnings guidance and confirmed the Origin Energy customer transition is on track. Analysts see additional growth opportunities
The New Criterion’s Tim Boreham explains the how and why behind Radiopharm Theranostics’ latest capital raising
Brokers highlight deregulation and scale benefits from the potential merger of Integral Diagnostics and Capitol Health
Deterra Royalties is looking to diversify away from iron ore royalties and provide for growth, in lithium in particular. The trade-off is a much-reduced dividend yield
Codan has surprised with the performance of its metal detection business, but it is the company’s communications business that has brokers excited
The next twelve months could be exciting for Dengue fever solutions seeker Island Therapeutics, the New Criterion’s Tim Boreham reports
Alternative asset manager Regal Partners has enjoyed impressive organic and inorganic funds under management growth in recent years and brokers see more ahead
With the costly decommissioning of the BMG field now behind it, Cooper Energy has outlined its strategy to exploit a tight east coast gas market
A lack of junior miner exploration in tough economic times has weighed on drill supplier Imdex, but brokers believe an upswing is not too far off